DS-1211b

· Daiichi Sankyo

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DS-1211b, covering 2024-12-31 to 2024-12-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study of DS-1211b in Individuals With PseudoXanthoma Elasticum [Phase 2]